Nature Medicine, Published online: 16 May 2025; doi:10.1038/d41591-025-00032-w
Three translational studies reveal elevated mitochondrial metabolism as a driver of age-related clonal hematopoiesis and suggest that targeting this process — for example, with metformin — could reduce the risk of associated diseases.
